News

News-Medical.Net on MSN9d
What makes H5N1 a pandemic risk and how can we stop it?
A new PEARLS article in PLoS Pathogens reviews the rapid evolution and pandemic potential of emerging influenza A viruses, ...
Infectious Disease Advisor23h
Avian Influenza Vaccine Trials, Prevention Should Be Prioritized in Pediatric Patients
Pediatric patients exhibited high risk for severe avian influenza A/H5N1, suggesting clinical therapeutic and vaccine trials should be prioritized in this population.
Cocrystal Pharma's Investigational Drug Candidate CC-42344 Demonstrates Strong Antiviral Potency Against The 2024 Highly Pathogenic H5N1 Avian Influenza Strain
CC-42344 was shown to be highly active against the highly pathogenic 2024 Texas H5N1 avian influenza strain <li /> The Company's virolo ...
News-Medical.Net on MSN3d
Experts explain how H5 avian influenza adapts to infect more animals
The Gs/Gd lineage of highly pathogenic H5 avian influenza viruses—including H5N1—has rapidly evolved, spreading globally and ...
US cancels more $700 million funding for Moderna bird flu vaccine
The Trump administration has cancelled a contract awarded to Moderna for the late-stage development of its bird flu vaccine ...